8,606
Total Claims
$1.8M
Drug Cost
1,337
Beneficiaries
$1,342
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-12%
Cost per patient vs peers
$1,342 vs $1,524 avg
Opioid Prescribing
0.1%
Opioid Rate
11
Opioid Claims
$26
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 6,676 claims · $130K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 777 | $742K |
| Rivaroxaban | 374 | $378K |
| Sacubitril/Valsartan | 242 | $226K |
| Evolocumab | 150 | $113K |
| Ticagrelor | 83 | $72K |
| Empagliflozin | 39 | $46K |
| Alirocumab | 47 | $29K |
| Clopidogrel Bisulfate | 1,066 | $17K |
| Evolocumab | 28 | $17K |
| Metoprolol Succinate | 864 | $13K |
| Ranolazine | 100 | $12K |
| Dapagliflozin Propanediol | 14 | $11K |
| Atorvastatin Calcium | 565 | $8,491 |
| Prasugrel Hcl | 57 | $4,011 |
| Enoxaparin Sodium | 34 | $3,928 |
Prescribing Profile
61
Unique Drugs
$1.4M
Patient Profile
75
Avg Age
45%
Female
1.98
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data